Rodems, Tamara S.
Juang, Duane S.
Stahlfeld, Charlotte N.
Gilsdorf, Cole S.
Krueger, Tim E. G.
Heninger, Erika
Zhao, Shuang G.
Sperger, Jamie M.
Beebe, David J.
Haffner, Michael C.
Lang, Joshua M. https://orcid.org/0000-0002-0943-8872
Funding for this research was provided by:
Office of the Assistant Secretary for Health (W81XWH-17-1-0096)
National Cancer Institute (1R01CA247479-01, 1R01CA247479-01)
Prostate Cancer Foundation (17CHAL15)
Article History
Received: 5 November 2021
Accepted: 18 February 2022
First Online: 10 March 2022
Declarations
:
: Blood samples were collected from patients after receiving written informed consent under a protocol approved by the IRB at the University of Wisconsin-Madison.
: Not applicable.
: D.J.B. holds equity in Salus Discovery LLC, which has licensed some of the technology described in the manuscript. D.J.B. also holds equity in BellBrook Labs LLC, Tasso Inc., Stacks to the Future LLC, Lynx Biosciences LLC, Onexio Biosystems LLC, Turba LLC, and is a consultant for Abbott Laboratories. D.S.J. holds equity in Turba LLC. T.S.R., D.S.J., D.J.B., and J.M.L. are listed as co-inventors on a patent application related to this work (U.S. Provisional Pat. Ser. No. 62/868296).